Patent · US Active

Aztreonam derivatives and uses thereof

US10280161B2 · kind B2 · utility

2Cited by

1References

27Claims

0Family size

Assignee

Arixa Pharmaceuticals, Inc. · US

Inventors

Eric M. Gordon · Pennington, US
Matthew Duncton · San Bruno, US
John Freund · Atherton, US

Key dates

Filing date	Oct 1, 2018
Grant date	May 7, 2019
Priority date	—
Expiry date	Oct 1, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with β-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.